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Abstract. The strueture of an HLA A2 4 functional van
ant (A2 4c) expressed on donor KLO has been exammed
by comparative peptide mapping with other HLA A2 anti-
gens of known strueture and radiochemical sequenemg
All the peptide differences between A2 4c and A2 1 could
be aecounted for by five amino acid changes at positions
9, 43, 66, 95, and 156 The natme of residues 9, 43, and
95 in A2 4c was determmed by sequencing to be identical
to those in A2 2Υ The nature of residue 156 in A2 4c
was also assigned as identical to that in A2 2Y on the basis
of the identity of the correspondmg peptide in lts Chro-
matographie companson with A2 2Y Position 66 was
unique to A2 4c It was determmed to be an Asn residue
instead of the Lys present in all other HLA-A2 antigens
of known strueture This was the only detected ammo acid
difference between A2 4c and A2 2Υ The results indicate
that, from a structural point of view, A2 4c IS most closely
related to the A2 2 subtype antigens and not to other A2 4
antigens The data are compatible with the assumption that
A2 4c was denved from A2 2 Υ by a Single point mutation
event
Introduction
Class I HLA antigens which appear to be virtually
homogeneous by tissue typing Serologie reagents aie, in
a number of cases, amenable to further subdivision by
cytolytic Τ lymphorytes (CTL), isoelectnc focusing
(IEF), or other cntei m The molecular analysis of this het-
erogeneity provides a basis to outline the pathways of
HLA diversification and to examine the influence of limit-
ed structural crunges in modulating the specificity of CTL
recogmtion Both of these aspects are particularly well ü-
lustrated in the case of HLA-A2 Smce the initial observa-
tion that influenza-virus-specific, HLA-A2 lestneted
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CTL failed to kill some virus-mfected A2 target cells (Bid
dison et al 1980), numerous studies have contnbuted to
establish that HLA-A2 IS a family of functionally and bio-
chemically distmguishable proteins Comprehensive
studies using alloreactive CTL populations and IEF de-
fined four subtypes designated A2 1, A2 2, A2 3, and
A2 4 (van der Poel et al 1983) These subtypes were also
partially distinguished by HLA A2-restncted CTL in a
vanety of antigenic Systems such as mfluenza and Epstein-
Barr viruses and minor H-Y and HA histocompatibihty
antigens (Biddison et al 1982, Gaston et al 1983,
Goulmy et al 1984) Further heterogeneity withm some
of these subtypes has been detected with both alloimmune
and self-restncted antigen-specific CTL, as well as with
monoclonal antibodies (Gotch et al 1985, van der Poel
et al 1986, Kennedy et al 1987)
The struetures of HLA-A2 1 (Koller and Orr 1985),
the two known vanants of A2 2 (A2 2F and A2 2Y), and
A2 3 have been determmed A2 2F differs from A2 1 by
three amino acid replacements at positions 43, 95, and
156, A2 2Y having an additional change at position 9
(Mattson et al 1987, Holmes et al 1987) A2 3andA2 1
differ in three clustered changes at positions 149, 152,
and 156 (Krangeletal 1983, Mattson et al 1987) Α rare
variant, OZB, defined functionally as A2 1 but havmg a
behavior in IEF-hke A2 3 (van der Poel et al 1986), was
shown to differ from A2 1 by a Single amino acid change
at position 236 in the a3 domain (Castano et al 1988)
The HLA-A2 4 subtype includes several vanants that are
distmguishable from A2 1 and among themselves by
CTL, but not by IEF (van der Poel et al 1986) The struc
ture of two A2 4 antigens, expressed on CLA (A2 4a) and
KNE cells (A2 4b), has been analyzed by peptide mapping
and protem sequencing, and each was found to differ from
A2 1 in a Single ammo acid residue at position 9 (Ezquerra
et al 1986) or 99 (Domenech et al 1988), respectively
Here we report on the strueture of a third A2 4 variant
KLO (hereon referred to as A2 4c) Unlike A2 4a and
A2 4b, A2 4c is structurally closer to the A2 2 subtype,
Ν Domencch α a] Slructure of HLA A2 4 vananl KLO
diffcnng fiom A2 1 in five amino acid scquence positions
and fiom A2 2Υ by onc Single amino acid changc
Materials and methods
I'uiφιautm oj radmilicmuallv labt In!IIIΛ Λ2 htm vthmns ΓΙΐί, lym
phoblistoid teil lim,·. JY (HLA A2 I B7) W149 (Hl Α A2 2Y
Bw58) andKICMHIAAl A2 4c B8 Bw50) were uscd as thc somcc
of nt itcnal Tlic r idiochenuc ll punhc Hion o[ <ill A2 hcavy ehams was
pulornicd by miniunoprecipilation with thc A2/Aw69 speuhc
monoclonal antibodv PA2 1 (Parhani and Bodmer 1978) and ann dcna
turcd HLA Α ß heavy cham serum as üesuibed (Γ/quena et dl 1986)
Piplult mitpi>m£aml',LiiMium% Ihe structural analysis ol HL Α A2 4c
by comp irative pepude inappmg and tadioehcniica] sequenung was as
deseubed (T/queiid el al 1986) 1 ryptic maps of joinlly digcslcd A2 1
or A2 2Y and A2 4c hc ivy chains wetx oblamcd by high pcrfoimancc
liquid chionutography (HPLC) in a gradicnl of ammonium acclalc and
acclunitrilc as desenbed in dclail ekewhere (Vcg.l et al I98*i) Turthcr
Iractlünation of soinc unresolved peptide nuxturcs w is caincd out in
HPLC with a gudicnl of dccfonitnle and Inlluoracclit acid loilowing
a desenbed procedure (Rojo et al 1987)
Results
A2 4c is structurully telatcd ίο ihe Λ2 2 •yubtype The ini-
tial strategy used for the stiuctural charactenzation of
A2 4c involved lts biochemical tompanson with A2 1 by
double-label tryptic mapping of Lys- and Arg labcled pep-
tides These two amino auds labcl all tryptic peptides
from both molccules except thc carboxyl-terminal ones
Ί he result of such companson is shown in Figurc 1 The
Lys-labeled map showed two l4C-labeled diflerence pep-
lides, K2 and K7, and a Ή labelcd difference peptide,
K3 The Arg-labelcd map displayed a more complex pat-
tern of differences, with five l4C-labeled (R8, R12, R28,
R29, and R32) and five 3H-labeled (R7, R9, R13, R30,
and R3I) difference peaks R30 was a mixtuie of two 3H-
labeled difference peptides as assessed by rechromatogra-
phy of this peak matcnal linder differem Chromatographie
condilions (not shown) Sequencing ol the A2 4c peptides
R7 and R9 yielded Ή-radioactivuy at cycles 8 and 1,
respectively (Fig IC) As will be shown below, thesedata
mdteate lhal R7 and R9 are the peptides spanmng residues
36-43 (FDSDAASR) and 44-48 (RMEPR), respectively,
and that Gln43 m A2 I was changed to Arg43 in A2 4c
To identify the nature ol the diflerence peptides shown
in Figure 1, Ala-, Trp-, Leu , and Tyr labeled maps were
obtamed The Ala-labeled map (Fig 2A) showed three
I 4C labeled (A3, A5, and A15) and thiee 3H-labeled (A2,
A6, and AI 6) difference peptides They eluted at the same
positions as R8, R12, R28, R7, R13, and R30, respective-
ly The sequence analyscs of the Ala-labeled difference
peptides arc shown in Figure 2B A2 and A3 both have
radioactivity at cycles 5 and 6, indicating that they are
theA2 4candA2 1 countciparts, respectively, of thc pep-
tide spanmng residues 36-43 (in A2 4c) oi 36-44 (in
A2 1) A5 and A6 each have ladioactivity at position 8
fhc only tryptic peptide from A2 1 with Ala at this posi-
tion is the glycopeptide, spanmng residues 83-97
(GYYNQSEAGSHTVQR) Thus, A5 and A6 are the
A2 1 and thc A2 4c counteipaits of this peptide, respec
tively Α15 was shown upon sequencing to have I 4C-
radioactivity at cycles 5, 6, and 9, consistent with this pep-
tide being the one spanmng residues 145-1^7 fiom A2 1
(HKWEAAHVAEQLR) A16 was recovered with veiy
Iow yiekl and could not be sequenced From lts elution
Position (see below) lt was assumed to bc the Ή-labeled
counterpart foi A15 The Iow yield ol this peptide is a
consequence ol ihe partial tryptic cleavage at Lys ] 4 6 Τ he
Trp labeled map (Fig 2C) was identical except foi the
presence of the A2 1 difference peak W9, eluting as Al^
and R28, and the A2 4c difference peak W10 eluting as
Α16 and R30 Sequencing of W9 and W10 showed radio
activity at cycle 3 in both of them, confirming then assign-
ment as the peptides spanmng lesiducs 145-157 in A2 I
and A2 4c, respectively The only other tryptic peptide
from A2 1 with Trp at this position, the one spanmng
residues 49-65, eluted with a much shoi tcr ι etention time
(unpublished observations) In the Lcu-labeled map (Fig
2D) a Single 3H-labeled difference peptide, L5, was appai -
ent, eluting as R13 and A6 Sequencing ol this peptide
showed radioactivity at cycle 13 (Fig 2D) This result,
together with thc elution position of L5 and the absence
of a l4C-l4bcled counterparl, indicaled thal it was the
glycopeptide from A2 4c, and thal this molecule pos-
sessed Leu at position 95 instead of the Val-iesidue
present in A2 1 In addition, a 14C-dilference peplide was
found, co-eluling with an identical peptide, upon
rechromatography ol L15undei diflerent Chromatograph-
ie conditions (not shown) Because of lts Iow yield, this
peptide could not be sequenced, but it was assumed to be
on the basis of lts elution position, the A2 I peplide span-
ningiesidues 145-157 No 3H-labcledcounteipait Ιοί this
peptide was found Thc Tyi -labcleü map showed two I4C
labeled (Y5 and Υ14) and two Ή-labeled (Y6 and Υ16)
dilference peaks (Fig 3A) Y5 and Y6 eluted in the same
positions as R12 or A5 and RI3, A6 oi L5, respectively
Sequencing of these two peptides yielded ladioaetivity at
cycles 2 and 3 in both of them (Fig 3B) These lesults
confirm that Y5 and Y6 are the A2 1 and A2 4c glycopep-
tides, respectively Υ14, which eluited as R29 was shown
upon sequencing to have radioactivity at cy< le 1 Fhis pep-
tide was the one spanmng residues 7-14 or 7- 17 Irom
A2 1 (YFFTSVSRPGR) because this is the only tryptic
peptide with Tyr at position 1 lacking Lys, and no differ-
ence peplides were found eluting late in the Lys-labeled
map (Fig 1) Y16, which eluted as R30, showed radioac-
livity at cycles 1 and 3, indicating that this was an A2 4c
peptide spanmng residues 7-14 oi 7-17, and the Phe«, in
A2 1 was changed to Tyr9 in A2 4L Equivalent peptides
Ν Domincch et ΛΙ Structurc ol HLA A2 4 vaiunl KLO
LYS
A2 1 ~JY ( )
A2 4c-KL0
ARG
A2 1 ~JY ( )
A2 4c-KL0
flg. 1 Α and Β shou tlie icvcise ph ise
HPLC tompinson ol tht, Lys labelui and
Aig I tbcled tryptic pepüdes icpcctively
between A2 l (JY)and A2 4t (KLO) Peaks
are numbered according to (heu relative elu
tion position withm dich pt-püde map Pe tks
icfcned to in tht tuet arc spccificd R5 and
R22 peaks were not difierencc pcptides as
assessed by rcchromatogiaphy oi e ich peak
linder diflcrent tonditioiib (sce Materials
and methods) Rechroniatogt tphy oi R29
iLvcaiecl tlic prustnee of a UC diifcicncc
pLptide co clutmg in this peak wilh an identi
cai pepude (sec texl) Ret-hiomatogiaphy of
R30 showed the presence oftwo Ή Jabeled
dii ference pcptides C shows th<- radiochem
ical stqucnoL anilyses ol R7 ind R9 Foi
cach peptidc 3H(A2 4c) and MC(A2 1)
ridioactivity (y ixis) is scparalely pJotitd
against the cyclc numbci (x IMS) in the ieft
ind iighl histociam iespccti\ely
for R31 and R32 weic not lound Howevcr, these two pep-
tidcs ate piobably ielatcd to R^O and R29, icspecüvely,
as a rcsull of paitial tiyptic cleavagc at the Argl4-Prol5
bond, as was prcviousiy observed (Ezqucna et al 1986)
Cleavage at this bond may vary between expenments, ai-
feetmg the yield ot the corresponding peptides
The tcsults from the compaiativc analysis of A2 4c
with A2 1 desenbed above are summanzcd in Figurc 4
Taken logether, they indicate the folbwing 1) A2 4c has
changes in the tiyptic peptides including all positions in
which A2 2Y and A2 1 are difterent, namely, residues
9, 43, 95, and 156 These peptides aecounted for all the
difference peaks detected in the Aig-, Ala-, Tip-, Leu-,
and Tyr-labeled maps 2) The changes between A2 1 and
A2 4c at positions 9, 43, and 95 <ue the same as those
present in A2 2Υ The existence of a chdngc at position
156 was not dircclly confirmed by sequencing 3) The
Lys labelcd difteiencc peptides werc not rclated to those
( h-ΟΙΧ WdQ Hc
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Iig 3 Α shows Ihc re\usc plmc
HPLC compitison ol the lyr 1 ibded
liyptit peplidei. bctWLCii A2 ! and
A2 4c 1Ϊ shows the sequenee malysei,
ot !he Tyr 1 ibeled diifuence peptides
Numbcring and sequenung of pepttdes
is as in TiguiL 1
analy/cd in the othci peptide maps suggesting thdt A2 4c
has onc or moie substitutions in addition to thosc present
in the A2 2Y subtype
Λ2 4< and A2 2Ydijfei In α singk amuw cmd change at
Position 66 In a second sei of expcumcnls Aig and Lys
iabeled compaiative peptide maps between A2 2Y and
A2 4c were obtaincd Τ he Aig Iabeled map was idcntita)
(1 ig *iA) The Lys Iabeled map showcd two 14C labelrd
(Kl and K4) dificrcnce peaks and onc 'H Iabeled (K2)
dilfcrencc peak (Fig 5B) All Ihiet differenet pentidcs
cluted in the samc positions as thosc in the compaialive
Lys Iabeled map wilhA2 1 (Fig 1A) suggesting thalthcy
were the samc peptides Ί he two 14C-di)fcrence peptidts
Kl and K4 showed radioactivity al cycle 2 and at cycles
1 and 3 tespectively (Fig *5B) Thisicsull wv^tompatible
with Kl and K4 being the peptides spannmg tcsidues
67-68 (VK) and 66-68 (KVK), tespeUively They would
have resulted from partial tryptic cleavage at the Arg65
and Lysö6 residues in A2 2Y The possibility that K4
was a longci peptide spannmg residues 66-75
(KVKAHSQTHR) was ruled out because the His Iabeled
map was identical (not shown) Scqucncing of the A2 4c
peptide K2 yicldcd radioactivity only at cycle 3 This sug
gested that K2 was the 66-68 peptide, and that Lys66 could
have changed in A2 4c The Val Iabeled map (Fig 6A)
showed only a I4C Iabeled (V2) and a 3H Iabeled (V3)
difference peptide eluting in the same positions as Κ1 and
K2 respectivcly As expected, sequencing of V2 and V3
yicldcd radioactivity at cycle 1 and al cycle 2 respectively
(Fig 6A) This reiultconfumed theassignmentoi thetwo
difleience peptides as thosc spannmg icsiducs 67-68 in
A2 2Y and 66-68 in A2 4c In addition, it indicated thal
Val(7 was not changed in A2 4c In the Val Iabeled map
Iig 2 Ashowslhe reverse plnse HPIC compinsonof the Ali hbütd tiypiiL peptides bLtWLenA2 1 and A2 4c Β shows \ht sujuenu, ui ilyscs
of Ihc Ala libclcd diftuencc peptides C and I) sluiw HK avcisc pli isc HPLC comp inson οΓ the Trp ] ibUt-d ind Leu 1 ibeltd tryptit peptides
n.spcclivcl> between A2 1 ind A2 4c Foi the comp irisoti of Γιρ libclcd pcpticks 'H libcltd maps fiom A2 1 ind A2 4c weit scpuatcly obt uned
ind weit plotlul (ogether 1 hc sequente in ilyscs of ilu corrcspoiulmg dii fcicnt-c peptides die included in each m ip L 5 w is pur f led by rechrom iloj,i ι
phy undcrdilfuui(condi!ionspnortoscqucnuii£. Hie Ι [Ί ptik mduded ι 'C dillucntcpcptide coelutingv ith in idenlicil onc (sectext) Numbci
mg ind scquenu% of pcpddcs is is m I i^ntc l
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lug. 4. Sumniary ol ihe amino acicl sequcncc
analyses of the HLA A2 differcncc. peptides
irom A2 1 (JY) and Λ2 4c (KLO) The assign
ment of euch singlc-ldbeled diflcrencc peptide
used for sequencing is shown The assignrncnts
of olhet differcnce peptidcs which were not se
lueiiccd and were identified on Ihe bjsis of their
.iution Position drt desenbed in Ihe lexl 1 IIL.SC
nc.ludi.A16 L 15, the I ys Idbcled and most of
hc Arg Idbeled peptides Anon ·> denote
idues idcntified dircctly by radiochcmiLal se
ijucnung The asttnsk under l rp
n i l fiom thu
W10 peptide mdiutes (hdl this restdue was not
dircctly sequeneed (st-e text) Animo acid dif fer
enecs betweui bolh molccutes Jre bau ei Tht
Standard onc lettci code for amitio acids is used
ARG
A2. 2Y-WT49 (- )
A2.4C-KL0
LYS
A2.2Y-WT49 (- )
A2.4c-KL0 )
O
Q
Ο
00 100 J
I"ig. 5. Α and Β show ihe levcrsc phast;
HPIX conipanson ol Arg labelcd and l ys
labi.led tryptic peptidcs respcctivcly, froin
A2 2Υ (WT49) and A2 4t (KLO) RlSwas
shown by rcchromatogiaphy under differenl
tonditions to consisl of a mixtuic of two
identical peptides C shows the sequenu:
analyses ol ihe Lys labelcd dificrciKC pep
ticlcs Ail thicc Kl, K2 and K4 peptidcs
wcic punlled from contamirunt idenlical
pcplides by rcchromalography under diflei
ent condihons pnor to sequenung Numbei
ing and sequenung ot peptides is as πι
Piguri, !
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h g (i Α and Β show the reveise phasc
HPLC tonipaiison ol V<il labded and Asn
Idbclcd tryptic peptides ixspt-cdvcly fioin
A2 2V and A2 4c For Ehe conipmfson ot
IIIL Asn labcled peplidcs " C labeled maps
Jrom both molecules were scpaialely ob
taincd and were plolled logethci The se
quence inalyses of the corresponding ditfer
ence peptides arc inciuded in each map
Numbenng and sequencing of peptides is as
in Figure 1 C is a summary ol the issign
ment and unino acid scqiiLncing of the do
tected difteiencc peptides bei'veen A2 4c
and A2 2Y Anow \ dcnole icsiducs idenli
hed dircttl> by tadiothemical SLqLicncing
The Single dUtcted differeiiLu bctw<.en bolh
molecules is bo\i<I
an equivalenl to the partial clcavage produet K4 wa^ not
obscivcd The nalinc oi the change at position 6o was
csiablished by obtaintng the Asn-Iabeled map (Fig 6B)
This amino acid was chosen because it ts fiequcntly found
at this posilion in dass I HLA antigens The only differ-
ence peak iound was the 3H-labeIed Nl, whose elution
position was the same as that of K2 and V3 Its sequencing
showed tadioactivity at cyde 1 (Fig 6B), confnming that
Lys6f) in A2 2Y was changed to Asn66 in A2 4c The
sequencing and assignment of the diifcrence peptides
iound in the companson ot A2 2Y and A2 4c is summa-
ii7ed in Figuie 6C
Discussion
The straiegy used foi the structural chaidcteiizatton of the
HLA-A2 4c antigen vanant expressed on KLO cells was
based on the biochemical companson oi all tryptic pep-
tides of the molecule with those of two other HLA-A2
antigens oi known structure HLA-A2 1 and HLA-A2 2Y
The reliabihty of this appioach has been discussed else-
wherc (Vega et al 1986, Domenech et al 1988) Com-
paiativeanalysis withHLA-A2 1 levealedthat A2 4c was
very similar to A2 2Y This antigen differs from A2 1
at positions 9, 43, 95, and 156 (Holmes et al 1987) The
loui changes were also prcsent in A2 4c This was estab
lishcd for lesidues 9 43, and 95 by diroct sequencing
The natuic ol the changc at position 156 could not bc de
termined by sequencing but it was, assigncd on the follow
ing bases
a) the existence ol a dillerencc peptide spanning residucs
145-157 inthecompansonol A2 4c with A2 1 Thispep
tide was labelcd in bolh A2 1 and A2 4c with Arg (one
of the two peptides in R30) Ala (AI6) and Trp (W10)
but was only recovered Irom A2 I (the dilfeience peak
within L15) and not Irom A2 4c upon Leu-Iabeling,
b) the identity ol the Arg labelcd map in the companson
ol A2 4c with A2 2Y
Furthermore this identity stiongly suggests that there
aie no additional substitutions within the Arg labelcd
dilfeience peptides detected in the companson ot A2 4c
with A2 I (Fig 4)
I he only peptide dil lei ences found between A2 4c and
A2 I whtch we/enofaecoumedforby the changes present
in A2 2Υ were those in the Lys-Iabelcd map (Pig 1A)
As expected these pcplides were also lound in the com
panson between A2 4c and A2 2Y (Fig 5) and shown
to rellcct a Single changc of LysM in A2 1 and A2 2Y to
Asn6(, in A2 4c Thus within the limitationsofthcpcplide
mapping analysis our results indicate lhat A2 4c dilfcis
froni A2 1 al positions 9, 43 66, 95 and 156 and from
A2 2Y only by the change at position 66
This Substitution which rcquiies a Single base change
dt the DNA level, aecounts for the IEF pattern of A2 4c
which IS idenfical with that ot A2 1 and IS one Charge unit
morc acidic than A2 2 (van der Pocl et al 1983) It lllus
trates that subtype classifications of class I antigens based
on IEF do not ncccssai ily reilect distinct subtype related
structural patterns Indeed, fiom a stiuctuial viewpoint,
A2 4c would bc a new vanant of the A2 2 subtype Figure
7 shows a companson ol all HLA A2 antigens of known
struclure Three gioups can cleaily be distmguished on
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the basis of thcir struetui al patterns Α first group includes
A2 2F A2 2Y and A2 4c, all of which as mentioned
above differ fiom A2 1 by the same changes al positions
43, 95, and 156 A2 2Υ and A2 4c both have the same
additional change at position 9, A2 4c having yet another
change at posilion 66 Α second group consists of A2 3,
which cliffers from A2 1 by three clusteied changes in the
<xl domain Α third gioup includes A2 4a, A2 4b, and
theA2 1/A2 3vanantOZB eachonedillenngfrom A2 1
by one amino acid changc located in the α ϊ , α2 οι a3
domains, rcspectively
The evolutionaiy relationships within the HLA A2
antigen family arc uncertain It has been suggesled that
Λ2 I and A2 2Kaie relativcly distant allelcs whose divei
gence probably involved multiple point mutalions and a
gcnetic exchange evenl Recipiocal recombination be
tween these two allelcs mighl have onginaled A2 21 and
A2 4a (Holmes et al 1987) The ongin ot A2 3 is most
easily explained by a Single gene conversion like event
from A2 1 (Mattson et al 1987, Holmes et al 1987) In
addition, Single point mutations from A2 1 could have
geneiatcd A2 4b and OZB (Domencch et al 1988
Castafio et al 1988), and a point mutaüon from A2 2Y
could havegiven riseto A2 4c Theseputativedivcrsifica
tion pathways are summanzed in Figure 8 Howevci it
should be emphasized that theic aie no systematic studies
on the racial disti ibution of the vanous HLA A2 subtypes
allhough A2 1 is the predominant subtype and A2 3 has
only been found in Onentals (van der Poel et al 1983)
Furthermore, the anccstial allele of the A2 lamily polen
tial donorsequences Ιοί theputative noniecipiocal recom
bination events, and possible mtcrmediatc forms have not
been identilied in addition completcDNA sequencesaic
necessary for all members of the lamily to subst tntiatc
postulated point mutations In the absence ol this infornia
tion, alternative evoiutionaiy pathways uumoi bc luled
out For instance, it is also possible that A2 4a and A2 2F
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A2 4c
A2 4α Α2 2F
I ig 8 Α hypothttical scheine showinfe the evolutionary diversilicalion
ül HLA A2 intigens Tluck artows indicate reciprocal or nonrcciproci!
DNA exchan^e events Urin cinaw. denote polnt mulation events
were inteimediate forms in a pathway going from A2 1
to A2 2Y Othtr alternatives have been discussed pievi
ously (Holmes et al 1987)
Position 66 which distinguishes A2 4c from A2 2Y
IS located in the long α helix fiom the a l domain which
IS a part of the antigen bmding and Τ ccll recognition Site
ot HLA A2 (Borjkman et al 1987) It is spatully close
to positions 9 and 95 which as mentioned above are also
changed in A2 4c and A2 2Y with respect to A2 1 Since
residue 66 is pointing towards the Site it would not be
expected to bc conspicuous for antibody recognition but
it could be important 1οι Τ cell lceognition
I h c A2 + B17 speulic monoclonal antibody MA2 1
(McMichael et al 1980) is thought to retogmze an epitope
mvolving residues 62-65 (Ways et al 1985) The in
troduction of a Single change or Lys to Ilc at position 66
in A2 1 through Site directed mutagenesis was sufficient
to completely abrogate ι ccognilion by this antibody sug
gesüng that lts determinant could also include rcsidue 66
(Santos Aguado et al 1988a) The leactivity of MA2 1
with KLO cells was examined by flow cytomelry analysis
and lound to be indistinguishable to that obtained with
othei A2 specific antibodies such as PA2 1 or CR11 351
(Russo et al 1983) (ddta not shown) Thus HLA A2 4c
expresses the antigemc determinant recognized by
MA2 1 This suggests that the change of Lys66 to Asn66
present in A2 4c does not dffect recognition by this anti
body It appears that the nature of residue 66 influeners
the epitope recognized by Μ Α2 1 so thdt strongly noncjn
seivativt substitutions (such as Ilc) at this position may
interlue with the binding of this antibody while other
changes (such as Asn) will not
With legard to the cellular lccognmon HLA A2 re
stueted Η Υ specific CTL do not recognize Η LA A2 4c
cells (Goulmy et al 1984 A2 4c is on targ„t cell no 1
in Tablc 1 from the latter reference) This absence of
lecognition cannot unambiguously bc attnbuted to the
change at position 66 because othei A2 2 target cells
which shdre with A2 4c several substitutions at other posi
tions also failed to be recognized by these CTLs (Goulmy
et al 1984) The pdrticipation of position 66 in allogencic
Τ cell recognition is suggested from the fdet that poly
clonal CTL raised against A2 2 antigens in a vanety of
responder mdividuals consistently showed dimmished
reactivity for A2 4 + target cells including the A2 4c
cells In addiüon a polyclonal CTL lme raised from
A2 responder cells stimulated with A2 4a+ cells could
distinguish between A2 2 and A2 4c target cells (van der
Pocl et al 1986) However in these studies it was not
established whether A2 2F alone or both A2 2F and
A2 2Y were represented in the target cell panel In the
former Situation the molecular Interpretation of the reac
tion patterns in terms of the role of position 66 would be
ambiguous because A2 2F and A2 4c also differ at posi
tion 9 More detailed studies concerning the ability of Τ
cells to distinguish between A2 2 and A2 4c antigcns aie
presently m progress (E Goulmy personal commumcd
tion) Another approach to demonstrate the importance of
residue 66 in allogeneic Τ cell recognition was the screen
mg of the reactivity pdtterns of a set of A2 specific CTL
clones against a panel of transfected target cells expressing
vanous Site directed mutants It was found that substitu
tion of Lys66 in A2 1 by He was sufficient to abrogate
recognition of the corresponding ti ansfected target cells
by six of nine clones amenable to analysis (Santos Aguado
et al 1988b)
The structural dissection of the HLA A2 antigen tami
ly may now be used as a basis for moie discnminative
CTL studies aimed at estabhshing the functional sig
nificance of subtype reldted polymoiphism within HLA
A2 The structurdl differences among subtypes often de
termine significant differences in CTL recognition
although many of these vanants have not yet been distm
guished by antibodies This is ol great functional sig
nificpnce because it implies that the immunological speci
ficuy of class I MHC antigens may be effiuently
modulated through limited structural diversification
ν hich can be attained by one or very few genetic events
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